Mary Tagliaferri
Chief Tech/Sci/R&D Officer at NEKTAR THERAPEUTICS
Net worth: 472 498 $ as of 2024-03-30
Profile
Mary A.
Tagliaferri was the founder of Bionovo, Inc. (founded in 2002) where she held the title of President, Secretary, Treasurer & Director from 2011 to 2012.
She is currently working as an Independent Director at Enzo Biochem, Inc. (since 2020), as a Director at Y-mAbs Therapeutics, Inc. (since 2024), and as the Chief Medical Officer & Senior Vice President at Nektar Therapeutics (since 2015).
In her former positions, she worked as a Director at Atossa Therapeutics, Inc., as an Independent Director at Rayzebio, Inc. (from 2021 to 2024), as the Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc., and as the Chief Medical Officer at Kanglaite USA, Inc. (from 2012 to 2014).
Dr. Tagliaferri obtained her undergraduate degree from Cornell University in 1988, her doctorate degree from The University of California, San Francisco in 2002, and her graduate degree from the American College of Traditional Chinese Medicine in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ENZO BIOCHEM, INC.
0.61% | 2024-01-30 | 312,383 ( 0.61% ) | 396 726 $ | 2024-03-30 |
| 2024-03-11 | 4,660 ( 0.01% ) | 75 772 $ | 2024-03-30 |
Mary Tagliaferri active positions
| Companies | Position | Start |
|---|---|---|
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2023-04-16 |
| ENZO BIOCHEM, INC. | Director/Board Member | 2020-11-16 |
| Y-MABS THERAPEUTICS, INC. | Director/Board Member | 2024-02-28 |
Former positions of Mary Tagliaferri
| Companies | Position | End |
|---|---|---|
| RAYZEBIO, INC. | Director/Board Member | 2024-02-25 |
| Kanglaite USA, Inc. | Chief Tech/Sci/R&D Officer | 2014-05-31 |
| BIONOVO INC. | Founder | 2012-05-31 |
| Lighten Up Enterprises International, Inc. | Chief Tech/Sci/R&D Officer | 2005-07-04 |
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Mary Tagliaferri
| Cornell University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
| American College of Traditional Chinese Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| RAYZEBIO, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Lighten Up Enterprises International, Inc. | Finance |
Bionovo, Inc.
 Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Bionovo, Inc. is a clinical drug discovery and development company, which is focused on developing drugs for the treatment of unmet medical needs in women's health and cancer. The company was founded by Isaac Cohen and Mary Tagliaferri in February 2002 and is headquartered in Emeryville, CA. | Health Technology |
| Y-mAbs Therapeutics, Inc. | |
| Kanglaite USA, Inc. |
- Stock Market
- Insiders
- Mary Tagliaferri
